Serum angiotensin converting enzyme activity streptozotocin-induced diabetic rats

Serum angiotensin converting enzyme activity streptozotocin-induced diabetic rats

___

  • 1. Kahn CB, Raman PG, Zic Z: Kidney size in diabetes mellitus. Diabetes 23:788- 792, 1974. 2. Seyer-Hansen K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23:643-46, 1983. 3. Seyer-Hansen K: Renal hypertrophy in streptozotocin diabetic rats. Clin Sci Mol Med 51:551-55, 1976. 4. Anderson S, Jung F, Ingelfinger JR. Renal renin-angiotensin system in diabetes functional, immunohistochemical, molecular biological correlations. Am J Physiol 265:F477- 486, 1993. 5. Jandeleit K, Rumble J, Jackson B, Cooper ME: Mezenteric vascular angiotensin-converting enzyme is increased in diabetes mellitus. Clin Exp Phar Physiol 19:343-47, 1992. 6. Aoyagi T, Wada T, Kojima F, Nagai M, Akanuma Y, Akanuma H, Umezawa H. Relation of blood glucose levels to the changes in plasma levels of various hydrolytic enzymes in diabetic patients. Biochem Int 10:821-27, 1985. 7. Ottlecz A, Bensaoula T, Eichberg J, Peterson RG: Angiotensin- converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na + K+-ATPase activity. Invest Ophthalmol Vis Sci 37 (11): 2157-64, 1996. 8. Giampietro O, Lenzi S, Sampietro T, Miccoli R, Navalesi R: Serum angiotensin- converting enzyme in diabetes mellitus: A negative report. Enzyme 35:102-105, 1986. 9. Liberman J: Serum angiotensiconverting enzyme: Elevation in diabetes mellitus. Ann Int Med 93:825- 26, 1981. 10. Erman A, van Dyk DJ, Chen-gal B, Iskera D, Giler S, Rosenfeld JB, Boner G: Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 23:615-20, 1993. 11. Valentovic MA, Ellott CW, Ball JG: The effect of streptozin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Res Commun Chem Pathol Pharmacol 58:27-38, 1987. 12. Holmquist B, Bunning P, Riordan JF: A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 95:540-44, 1979. 13. Drury PL, Smith GM, Ferriss JB: Increased vasopressor responsiveness to angiotensin II in type I (insulin dependent) diabetic patients without complication. 27:174-179, 1984. 14. Hsueh WA. Effect of the reninangiotensin system in the vascular disease of type II diabetes mellitus. Am J Med 92:13S-19S, 1992. 15. Hallab M, Bled F, Suraniti S, Girault A, Fressinaud P, Marre M: Elevated serum angiotensin I converting enzyme activity in type I insulin-dependent diabetic subjects with persistent microalbuminuria (Abstract). Diabetologia 34:A17, 1991. 16. van Dyk DJ, Erman A, Erman T, Chengal B, Sulkes J, Boner G: Increased serum angiotensin converting enzyme activity in type I diabetic patients. Eur J Clin Invest 24:463-467, 1994. 17. Campell DJ: Circulating tissue angiotensin systems. J Clin Invest 79:1-6, 1987.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK